Albireo Pharma Revenue, Growth & Competitor Profile

DBA (A DEVELOPMENT STAGE COMPANY)
DBA Biodel Inc

Company Profile & Annual Report for Albireo Pharma

Access the complete profile.

Albireo Pharma Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing 812 Personal & Laundry Services
Address	53 State Street 19th Floor Boston, MA 02109

Note: Revenues for privately held companies are statistical evaluations.


Albireo Pharma's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Albireo Pharma's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Albireo Pharma is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Albireo Pharma Annual Revenue and Growth Rate

Albireo Pharma	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Albireo Pharma's revenues are gauged from an analysis of company filings.

Albireo Pharma's Income Statement (based on Industry Averages)

Albireo Pharma P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Albireo Pharma is developing and marketing. Albireo Pharma doesn't have any recent trademark applications, indicating Albireo Pharma is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
RESCUGON Pharmaceutical preparations for the treatment of endocrine disorders	04/20/2015
QUIXAGON Pharmaceutical preparations for the treatment of endocrine disorders	04/20/2015
MYGLUKA Pharmaceutical preparations for the treatment of endocrine disorders	04/20/2015

See all trademarks and details in the Full Report.

Market Share of Albireo Pharma's Largest Competitors

A competitive analysis shows these companies are in the same general field as Albireo Pharma, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Albireo Pharma. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BROAD INSTITUTE	Cambridge, MA	100
BEIGENE USA	Cambridge, MA	69
ALNYLAM PHARMACEUTICALS	Cambridge, MA	52
SAGE THERAPEUTICS	Cambridge, MA	47
INTELLIA THERAPEUTICS	Cambridge, MA	35
IPSEN BIOPHARMACEUTICALS	Cambridge, MA	34

Other Companies at 53 State Street, Boston MA

Company	Headquarters	Revenue ($ MM)
FIRST-CITIZENS BANK & TRUST	Boston, MA	100
VEOLIA NORTH AMERICA LLC.	Boston, MA	13
GOODWIN PROCTER	Boston, MA	8
VICINITY ENERGY OKLAHOMA CITY	Boston, MA	4
GREER LABORATORIES	Boston, MA	4

Future Competition: Albireo Pharma's Fastest Growing Competitors

These companies are in the same general field as Albireo Pharma and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)